A Phase 2 Microcurrent Therapy Study in AMD
Recruiting Not Applicable NCT06662162
Study Description
Evaluating the Safety and Effectiveness of a Microcurrent Device for Age-Related Macular Degeneration
Study Details
- Registry ID:
- NCT06662162
- Conditions:
- Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
- Phase:
- Not Applicable
- Target Enrollment:
- 100 participants
- Start Date:
- Age Range:
- 60–999 years
- Healthy Volunteers:
- No
Study Locations (11 sites)
-
King's College Hospital
London, United Kingdom -
London North West University Healthcare
Middlesex, United Kingdom -
University Retina & Macula Associates
Lemont, Illinois, United States -
Adelaide Eye & Retina Centre
Adelaide, Victoria, Australia -
Cerulea
East Melbourne, Victoria, Australia -
Eye Clinic Albury-Wodonga
Albury, New South Wales, Australia -
Hobart Eye Surgeons
Hobart, Tasmania, Australia -
Save Sight Institute
Sydney, New South Wales, Australia -
Sydney Eye Hospital
Sydney, New South Wales, Australia -
Southern Eye Specialist
Christchurch, New Zealand -
Auckland Eye Limited
Remuera, Auckland, New Zealand
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.